Clinical Trials Logo

Dissociative Disorders clinical trials

View clinical trials related to Dissociative Disorders.

Filter by:

NCT ID: NCT00630981 Unknown status - Clinical trials for Dissociative Disorders

Psychotherapy and Pharmacotherapy in Dissociative Disorders

Start date: February 2008
Phase: N/A
Study type: Observational

The purpose of this observational study is to measure the efficacy of a specific combined treatment (psychotherapy and pharmacotherapy) on patients with dissociative disorders, in terms of patients with a favorable outcome by means of the Dissociative Experiences Scale (DES).

NCT ID: NCT00548197 Completed - Clinical trials for Diabetic Retinopathy

Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment

Start date: February 2007
Phase: Phase 1
Study type: Interventional

Vitreoretinal surgery for epiretinal proliferation tractional retinal detachment associated with proliferative diabetic retinopathy (PDR) is often complicated by hemorrhage from fibrovascular tissue. To control the bleeding during tissue dissection multiple measures and techniques are used. Bevacizumab is an anti VEGF antibody which has been used to induce regression of ocular neovascularization. Its intraocular injection has been increasingly used for treatment of choroidal neovascularization (CNV) associated with age related macular degeneration (AMD) with fairly good success.Also it has been shown to be effective for treatment of PDR complicated with vitreous hemorrhage and iris neovascularization. We hypothesized that if anti-angiogenic agents, such as bevacizumab are injected into the vitreous cavity before vitrectomy in cases of PDR; there may be partial regression of neovascularization resulting in less intraoperative (and postoperative) hemorrhage. This can make the operation easier and shorter and lessen the need for intraocular cautery.. In this study diabetic patients who are candidated for vitrectomy with similar complexity scores will be randomized to preoperative injection or no injection of 2.5 mg Bevacizumab .In the injection group, 2.5 mg of bevacizumab (0.1 ml of commercially available Avastin vial, Genentech, inc. South San Francisco, CA) will be injected into the vitreous 3-5 days before operation. During each operation, the number of endodiathermy applications, backflush needle applications and the duration of surgery will be recorded by an independent observer. Also, type of tamponade, post operation vitreous hemorrhage and 3 months postoperative visual acuities wil be recorded. all these parameters will be compared in two groups.

NCT ID: NCT00485199 Completed - Retinal Detachment Clinical Trials

Pneumatic Retinopexy Versus Vitrectomy With Gas for Retinal Detachment Due to Myopic Macular Hole

RDMH
Start date: January 2005
Phase: N/A
Study type: Interventional

To undertake a prospective randomized clinical study for treating retinal detachment due to myopic macular holes, utilizing pneumatic retinopexy versus pars plana vitrectomy with gas tamponade.To determine the efficiency of pneumatic retinopexy with C3F8 in the treatment of retinal detachment due to myopic macular hole.

NCT ID: NCT00404209 Terminated - Retinal Detachment Clinical Trials

Pressurized PPV 23GA Vitrectomy in Complicated Diabetic Tractional Retinal Detachment

Start date: March 2007
Phase: Phase 3
Study type: Interventional

To investigate the feasibility and advantages of using pressurized perfluorocarbon liquid (PCL) perfusion to remove vitreous during suction-cutting 23 GA vitrectomy using a dual, dynamic drive (3D)technology, in complicated retinal detachment surgeries.

NCT ID: NCT00403702 Withdrawn - Retinal Detachment Clinical Trials

Comparison High-density Silicone Oils in Retinal Detachment

Start date: August 2006
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of the study is to compare the safety, intraocular adverse effects and the anatomic and functional outcome with two endotamponade silicone oil after a 3-month in complex inferior retinal re-detachments.

NCT ID: NCT00370279 Recruiting - Clinical trials for Pseudophakic Retinal Detachment

Surgical Management of Pseudophakic and Aphakic Retinal Detachment; a Randomized Clinical Trial

Start date: September 2005
Phase: Phase 3
Study type: Interventional

To compare the visual and anatomical outcomes and complications of four surgical techniques (1- scleral buckling, 2- primary vitrectomy without encircling band, 3- primary vitrectomy with encircling band, 4- triamcinolone assisted vitrectomy) for management of pseudophakic and aphakic retinal detachment

NCT ID: NCT00159965 Completed - Depression Clinical Trials

Treatments for Psychogenic Nonepileptic Seizures (NES)

NES
Start date: December 2003
Phase: Phase 4
Study type: Interventional

The investigators propose that treatment of the comorbid disorders (depression, anxiety, and impulsivity) with sertraline in patients with lone psychogenic nonepileptic seizures (NES), will result in a decreased number of NES. The purpose of this study is to provide pilot testing and data to inform the future randomized controlled trial based on the hypothesis.